No menu items!

J&J, P&G sued after FDA panel ruling on cold medicine decongestant Reuters via biedexmarkets.com

Stock MarketsJ&J, P&G sued after FDA panel ruling on cold medicine decongestant Reuters...

© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

By Jonathan Stempel

(Reuters) – A new lawsuit accuses Johnson & Johnson (NYSE:) and Procter & Gamble (NYSE:) of deceiving consumers about decongestant cold medicines containing an ingredient that a unanimous U.S. Food and Drug Administration advisory panel this week declared ineffective.

According to a proposed class action on Wednesday filed in Pensacola, Florida, federal court, the companies knew or should have known by 2018 that their marketing claims about products containing phenylephrine were false and misleading.

That year was when new FDA guidance for evaluating symptoms related to nasal congestion demonstrated that earlier data about phenylephrine’s effectiveness could no longer be relied upon, the complaint said.

The plaintiff, Steve Audelo, said he bought Johnson & Johnson’s Sudafed PE and Benadryl Allergy Plus Congestion, and Procter & Gamble’s Vicks NyQuil, based on the companies’ “false and deceptive” claims that the products worked.

Audelo, a Florida resident, said the claims violated that state’s consumer protection laws. He is seeking at least $5 million in damages for people who bought the products in the United States in the last five years.

Johnson & Johnson and Procter & Gamble did not immediately respond on Thursday to requests for comment.

The FDA panel reviewed several studies before concluding that phenylephrine was essentially no better than a placebo.

According to an agency presentation, about 242 million products with phenylephrine were sold in the United States last year, generating $1.76 billion of sales and accounting for about four-fifths of the market for oral decongestants.

Another decongestant, pseudoephedrine, is considered safe, but has been moved behind pharmacy counters because people can process it illegally into methamphetamine. Sales of oral products that contain it totaled $542 million last year.

The FDA generally follows but does not always adopt its advisory panels’ recommendations. It could take months to decide whether to pull products with phenylephrine from store shelves.

The case is Audelo v Johnson & Johnson Consumer Inc et al, U.S. District Court, Northern District of Florida, No. 23-24250.

Unlock Your Profit Potential: Actionable Stock News, Trading Signals, and More for Savvy Investors

Supercharge Your Investment Strategy Today with the Ultimate Streaming Platform and Premium Tools

Explore more

Unlock Your Profit Potential: Actionable Stock News, Trading Signals, and More for Savvy Investors

Supercharge Your Investment Strategy Today with the Ultimate Streaming Platform and Premium Tools

AMD stock - Advanced Micro Devices Stock: Bull Case vs. Bear Case

AMD's AI Outlook: Why the Best May Be Yet to Come

While at first it may seem like AI-related catalysts are now baked into the valuation of AMD stock, that's not necessarily the case.
AT&T says tests at some lead cable sites show no public health risk By Reuters

AT&T’s CFO Confident in Exceeding $16 Billion Free Cash Flow Forecast...

© Reuters. AT&T Inc (NYSE:).'s Chief Financial Officer expressed optimism on Thursday regarding the company's full-year forecast for free cash flow, which is expected...
Nigeria's Tinubu defends win in disputed presidential poll By Reuters

Factbox-Key dates on Trump’s overlapping legal and political calendars Reuters via...

© Reuters. Republican presidential candidate and former U.S. President Donald Trump speaks as he campaigns at the Iowa State Fair in Des Moines, Iowa,...
Exclusive-SoftBank prepares new round of layoffs at Vision Fund -sources By Reuters

US raises Mexico air safety rating in boost for country’s airlines...

© Reuters. A view shows an area of the Felipe Angeles International airport, in Zumpango, on the outskirts of Mexico City, Mexico August 25,...
Immuneering Announces Participation in March Investor Conferences - Immuneering (NASDAQ:IMRX)

First Wave BioPharma Announces Exercise of Warrants and Issuance of New...

BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the "Company") FWBI, a clinical-stage...
ECB's Villeroy sees inflation peak in first half of year, no risk of recession By Reuters

Iran ready to implement Qatar-mediated prisoner swap deal with U.S.

© Reuters. FILE PHOTO: The Iranian and U.S. flags are seen printed on paper in this illustration taken January 27, 2022. REUTERS/Dado Ruvic/Illustration/File Photo DUBAI...
This U.S. Cannabis Company Is Targeting The German Retail Market: Sets Sights On Building Four Clubs - CBD Of Denver (OTC:CBDD)

This U.S. Cannabis Company Is Targeting The German Retail Market: Sets...

Colorado-based CBD of Denver, Inc. CBDD announced Thursday that its wholly-owned subsidiary, Luxora, has taken a significant step into the European cannabis market by...
Immuneering Announces Participation in March Investor Conferences - Immuneering (NASDAQ:IMRX)

Thinking about trading options or stock in NVIDIA, Apple, Enbridge, AT&T,...

NEW YORK, Sept. 14, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVDA, AAPL, ENB, T, and GOOGL. ...
AMD stock - Advanced Micro Devices Stock: Bull Case vs. Bear Case

AMD's AI Outlook: Why the Best May Be Yet to Come

While at first it may seem like AI-related catalysts are now baked into the valuation of AMD stock, that's not necessarily the case.
AT&T says tests at some lead cable sites show no public health risk By Reuters

AT&T’s CFO Confident in Exceeding $16 Billion Free Cash Flow Forecast...

© Reuters. AT&T Inc (NYSE:).'s Chief Financial Officer expressed optimism on Thursday regarding the company's full-year forecast for free cash flow, which is expected...
Nigeria's Tinubu defends win in disputed presidential poll By Reuters

Factbox-Key dates on Trump’s overlapping legal and political calendars Reuters via...

© Reuters. Republican presidential candidate and former U.S. President Donald Trump speaks as he campaigns at the Iowa State Fair in Des Moines, Iowa,...
Exclusive-SoftBank prepares new round of layoffs at Vision Fund -sources By Reuters

US raises Mexico air safety rating in boost for country’s airlines...

© Reuters. A view shows an area of the Felipe Angeles International airport, in Zumpango, on the outskirts of Mexico City, Mexico August 25,...
Immuneering Announces Participation in March Investor Conferences - Immuneering (NASDAQ:IMRX)

First Wave BioPharma Announces Exercise of Warrants and Issuance of New...

BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. ("First Wave BioPharma" or the "Company") FWBI, a clinical-stage...
ECB's Villeroy sees inflation peak in first half of year, no risk of recession By Reuters

Iran ready to implement Qatar-mediated prisoner swap deal with U.S.

© Reuters. FILE PHOTO: The Iranian and U.S. flags are seen printed on paper in this illustration taken January 27, 2022. REUTERS/Dado Ruvic/Illustration/File Photo DUBAI...
This U.S. Cannabis Company Is Targeting The German Retail Market: Sets Sights On Building Four Clubs - CBD Of Denver (OTC:CBDD)

This U.S. Cannabis Company Is Targeting The German Retail Market: Sets...

Colorado-based CBD of Denver, Inc. CBDD announced Thursday that its wholly-owned subsidiary, Luxora, has taken a significant step into the European cannabis market by...
Immuneering Announces Participation in March Investor Conferences - Immuneering (NASDAQ:IMRX)

Thinking about trading options or stock in NVIDIA, Apple, Enbridge, AT&T,...

NEW YORK, Sept. 14, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVDA, AAPL, ENB, T, and GOOGL. ...